Drug-related Problems and their Predictors among Breast Cancer Patients Receiving Chemotherapy in National Cancer Institute, Malaysia

被引:0
|
作者
Abdulrahman, Egbal [1 ]
Kassab, Yaman Walid [1 ]
Jamaluddln, Nurul Adilla Hayat [1 ]
Iqbal, Muhammad Shahid [2 ]
Khan, Salah-Ud-Din [3 ]
Al-Saikan, Fahad, I [2 ]
Ahmed, M. Azmin [4 ]
机构
[1] Univ Cyberjaya, Dept Hosp & Clin Practice, Fac Pharm, Cyberjaya 63000, Selangor, Malaysia
[2] Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj 11942, Saudi Arabia
[3] Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Dept Biochem, Riyadh, Saudi Arabia
[4] Univ Malaysia, Sch Pharm, Kuala Lumpur, Malaysia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2021年 / 40卷 / 03期
关键词
adverse drug reactions (ADRs); breast cancer; drug-related problems (DRPs); National Cancer Institute (IKN); risk factors; EVENTS; ERRORS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast cancer patients receiving chemotherapy are at high risk of drug-related problems (DRPs), as it is estimated that around 5-10% of hospital admissions are due to DRPs. Breast cancer management is a leading cause of these DRPs in which the drug toxicity is considered as the main cause that makes DRPs very prevalent. Hence, this study aimed to assess DRPs and their predictors among breast cancer patients receiving chemotherapy at the National Cancer Institute (IKN), Malaysia. Breast cancer patients with any stage and type aged >= 18 years and receiving chemotherapy between January and December 2017 were included. DRPs were classified according to a modified form of the Pharmaceutical Care Network Europe (PCNE). Statistical analysis was done by Statistical Package for Social Science (SPSS) software version 24. For categorical data, the Chi-squared test was used to determine the association of patients' characteristics and the occurrence of DRPs. A p < 0.05 was assumed as statistically significant among the obtained results. Overall, 100 patients were included in the study. The majority was Malays 59 (59%) and aged between 25-67 years. A total of 157 DRPs were identified in 78 patients, translating to a prevalence of 78%. Adverse drug reactions (ADRs) were the most common DRPs (47.8%). The most frequent ADR was neutropenia which encountered in 50 patients with prevalence 14.6% of the total ADRs followed by chemotherapy induced nausea and vomiting (CINV) 42 (12.5%). Other DRPs such as drug-drug interactions, drug selection and drug dosing were less common. It was predicted with increasing the number of co-morbidities, DRPs were more likely to occur (OR = 2.279, 95%, CI 1.098-4.730, p = 0.027). DRPs were common in breast cancer patients receiving chemotherapy. The predominant proportion of DRPs was ADRs. Number of co-morbidities was a predictor of the DRPs among the studied cohort of the patients.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 50 条
  • [21] Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients A hospital-based observational study
    Tsuji, Daiki
    Ikeda, Midori
    Yamamoto, Keisuke
    Nakamori, Harumi
    Kim, Yong-Il
    Kawasaki, Yohei
    Otake, Aki
    Yokoi, Mari
    Inoue, Kazuyuki
    Hirai, Keita
    Nakamichi, Hidenori
    Tokou, Umi
    Shiokawa, Mitsuru
    Itoh, Kunihiko
    MEDICINE, 2016, 95 (44)
  • [22] PREDICTORS OF YOGA USE AMONG PATIENTS WITH BREAST CANCER
    Desai, Krupali
    Bowman, Marjorie A.
    Galantino, Mary Lou
    Hughes-Halbert, Chanita
    Vapiwala, Neha
    DeMichele, Angela
    Mao, Jun J.
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2010, 6 (06) : 359 - 363
  • [23] Frequency and predictors of caregiver burden among patients with cancer receiving palliative cancer treatment
    Torres-Tenor, Juan Luis
    Bernal-Hertfelder, Elsa
    Pertejo-Fernandez, Ana
    Ramon-Patino, Jorge Luis
    Redondo, Andres
    Alonso-Babarro, Alberto
    Bruera, Eduardo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [24] Clinical Predictors of Chemotherapy-induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
    Shih, Vivianne
    Wan, Hee Siew
    Chan, Alexandre
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (03) : 444 - 452
  • [25] Body Image and Its Predictors in Breast Cancer Patients Receiving Surgery
    Chen, Chun-Lan
    Liao, Mei-Nan
    Chen, Shu-Ching
    Chan, Pei-Ling
    Chen, Shin-Cheh
    CANCER NURSING, 2012, 35 (05) : E10 - E16
  • [26] Healthcare professionals' agreement on clinical relevance of drug-related problems among elderly patients
    Bech, Christine Flagstad
    Frederiksen, Tine
    Villesen, Christine Tilsted
    Hojsted, Jette
    Nielsen, Per Rotboll
    Kjeldsen, Lene Juel
    Norgaard, Lotte Stig
    Christrup, Lona Louring
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 119 - 125
  • [27] Predictors of Breast Cancer among Women in a Northern State of Malaysia: a Matched Case-control Study
    Matalqah, Laila
    Radaideh, Khaldoon
    Yusoff, Zuraidah Mohd
    Awaisu, Ahmed
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (06) : 1549 - 1553
  • [28] Energy Balance in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy
    Michelle N. Harvie
    I.T. Campbell
    A. Baildam
    A. Howell
    Breast Cancer Research and Treatment, 2004, 83 : 201 - 210
  • [29] Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy
    de Jong, N
    Candel, MJJM
    Schouten, HC
    Abu-Saad, HH
    Courtens, AM
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 896 - 905
  • [30] Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy
    Julia E. Inglis
    Michelle C. Janelsins
    Eva Culakova
    Karen M. Mustian
    Po-Ju Lin
    Ian R. Kleckner
    Luke J. Peppone
    Supportive Care in Cancer, 2020, 28 : 1411 - 1418